1. Home
  2. BBDC vs AVBP Comparison

BBDC vs AVBP Comparison

Compare BBDC & AVBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BBDC
  • AVBP
  • Stock Information
  • Founded
  • BBDC 2006
  • AVBP 2021
  • Country
  • BBDC United States
  • AVBP United States
  • Employees
  • BBDC N/A
  • AVBP N/A
  • Industry
  • BBDC Diversified Financial Services
  • AVBP
  • Sector
  • BBDC Finance
  • AVBP
  • Exchange
  • BBDC Nasdaq
  • AVBP NYSE
  • Market Cap
  • BBDC 961.0M
  • AVBP 862.8M
  • IPO Year
  • BBDC 2007
  • AVBP 2024
  • Fundamental
  • Price
  • BBDC $9.28
  • AVBP $20.77
  • Analyst Decision
  • BBDC Buy
  • AVBP Strong Buy
  • Analyst Count
  • BBDC 3
  • AVBP 8
  • Target Price
  • BBDC $9.67
  • AVBP $39.00
  • AVG Volume (30 Days)
  • BBDC 416.4K
  • AVBP 498.9K
  • Earning Date
  • BBDC 08-06-2025
  • AVBP 08-13-2025
  • Dividend Yield
  • BBDC 11.21%
  • AVBP N/A
  • EPS Growth
  • BBDC N/A
  • AVBP N/A
  • EPS
  • BBDC 0.94
  • AVBP N/A
  • Revenue
  • BBDC $280,800,000.00
  • AVBP N/A
  • Revenue This Year
  • BBDC N/A
  • AVBP $85.82
  • Revenue Next Year
  • BBDC N/A
  • AVBP N/A
  • P/E Ratio
  • BBDC $9.91
  • AVBP N/A
  • Revenue Growth
  • BBDC N/A
  • AVBP N/A
  • 52 Week Low
  • BBDC $7.66
  • AVBP $15.47
  • 52 Week High
  • BBDC $10.85
  • AVBP $36.37
  • Technical
  • Relative Strength Index (RSI)
  • BBDC 59.33
  • AVBP 39.60
  • Support Level
  • BBDC $8.98
  • AVBP $20.00
  • Resistance Level
  • BBDC $9.18
  • AVBP $23.27
  • Average True Range (ATR)
  • BBDC 0.11
  • AVBP 1.51
  • MACD
  • BBDC 0.02
  • AVBP -0.49
  • Stochastic Oscillator
  • BBDC 97.44
  • AVBP 13.28

About BBDC Barings BDC Inc.

Barings BDC Inc operates as a closed-end, non-diversified investment company and has elected to be treated as a business development company. The company's investment objective is to generate current income by investing directly in privately held middle-market companies to help these companies fund acquisitions, growth, or refinancing. Barings employs fundamental credit analysis and targets investments in businesses with low levels of cyclicality and operating risk relative to other businesses in this market segment. The holding size of each position will generally be dependent upon a number of factors including total facility size, pricing and structure, and the number of other lenders in the facility.

About AVBP ARRIVENT BIOPHARMA INC

ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. It seeks to utilize the team's deep drug development experience to maximize the potential of the lead development candidate, furmonertinib, and advance a pipeline of novel therapeutics, such as next-generation antibody-drug conjugates, through approval and commercialization in patients suffering from cancer, with an initial focus on solid tumors.

Share on Social Networks: